Integral Ad Science (NASDAQ:IAS) Shares Gap Up - Still a Buy?

Key Points

• Integral Ad Science's stock opened at $10.18, up from a previous close of $8.46, reflecting significant interest with a trading volume of 30,528,560 shares.
• Research analysts generally have a positive outlook, with a consensus rating of "Moderate Buy" and a target price averaging $13.55.
• The company reported better-than-expected earnings of $0.07 EPS for the last quarter, exceeding estimates and generating revenues of $149.20 million.

Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) gapped up before the market opened on Wednesday . The stock had previously closed at $8.46, but opened at $10.18. Integral Ad Science shares last traded at $10.20, with a volume of 30,528,560 shares.

Wall Street Analyst Weigh In

Several research analysts have commented on IAS shares. Stifel Nicolaus raised their target price on Integral Ad Science from $13.00 to $14.00 and gave the stock a "buy" rating in a research note on Tuesday, July 22nd. Wall Street Zen raised Integral Ad Science from a "hold" rating to a "buy" rating in a report on Sunday, August 10th. Raymond James Financial dropped their price objective on Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating on the stock in a research report on Friday, August 8th. Finally, Barclays raised their price objective on Integral Ad Science from $9.00 to $10.00 and gave the stock an "equal weight" rating in a research note on Friday, August 8th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Integral Ad Science has a consensus rating of "Moderate Buy" and a consensus target price of $13.55.

Integral Ad Science Stock Up 20.4%

The stock has a market cap of $1.69 billion, a PE ratio of 29.96, a P/E/G ratio of 1.20 and a beta of 1.57. The business has a 50 day moving average price of $8.60 and a 200 day moving average price of $8.16.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.03. The company had revenue of $149.20 million for the quarter, compared to the consensus estimate of $143.02 million. Integral Ad Science had a return on equity of 5.00% and a net margin of 9.79%. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, research analysts predict that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Integral Ad Science news, CEO Lisa Utzschneider sold 14,904 shares of the firm's stock in a transaction on Tuesday, July 8th. The stock was sold at an average price of $8.31, for a total transaction of $123,852.24. Following the completion of the sale, the chief executive officer owned 379,316 shares of the company's stock, valued at $3,152,115.96. This trade represents a 3.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 35,073 shares of company stock worth $289,641 in the last quarter. Company insiders own 2.00% of the company's stock.

Institutional Investors Weigh In On Integral Ad Science

A number of institutional investors have recently modified their holdings of the company. American Century Companies Inc. purchased a new position in Integral Ad Science in the first quarter valued at $711,000. Delphi Management Inc. MA purchased a new stake in Integral Ad Science during the 2nd quarter worth about $539,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Integral Ad Science by 42.7% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 155,010 shares of the company's stock valued at $1,618,000 after purchasing an additional 46,395 shares during the last quarter. Envestnet Asset Management Inc. lifted its holdings in shares of Integral Ad Science by 165.6% in the 1st quarter. Envestnet Asset Management Inc. now owns 84,471 shares of the company's stock valued at $681,000 after purchasing an additional 52,664 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Integral Ad Science by 15.9% in the 1st quarter. Bank of New York Mellon Corp now owns 291,079 shares of the company's stock valued at $2,346,000 after purchasing an additional 39,988 shares during the last quarter. 95.78% of the stock is owned by institutional investors and hedge funds.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.